Wikidata

(Q27671432)

English

Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK)

scientific article

In more languages

Statements

title
Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK) (English)
0 references
author name string
J Jean Cui
series ordinal
1
0 references
Michelle Tran-Dubé
series ordinal
2
0 references
Hong Shen
series ordinal
3
0 references
Mitchell Nambu
series ordinal
4
0 references
Pei-Pei Kung
series ordinal
5
0 references
Mason Pairish
series ordinal
6
0 references
Lei Jia
series ordinal
7
0 references
Jerry Meng
series ordinal
8
0 references
Lee Funk
series ordinal
9
0 references
Iriny Botrous
series ordinal
10
0 references
Michele McTigue
series ordinal
11
0 references
Neil Grodsky
series ordinal
12
0 references
Kevin Ryan
series ordinal
13
0 references
Ellen Padrique
series ordinal
14
0 references
Gordon Alton
series ordinal
15
0 references
Sergei Timofeevski
series ordinal
16
0 references
Shinji Yamazaki
series ordinal
17
0 references
Qiuhua Li
series ordinal
18
0 references
Helen Zou
series ordinal
19
0 references
James Christensen
series ordinal
20
0 references
Barbara Mroczkowski
series ordinal
21
0 references
Steve Bender
series ordinal
22
0 references
Robert S Kania
series ordinal
23
0 references
Martin P Edwards
series ordinal
24
0 references
publication date
22 September 2011
0 references
volume
54
0 references
page(s)
6342-63
0 references
issue
18
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q27671432&oldid=1951782744"